We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

190 hedge funds and large institutions have $1.52B invested in Cardiovascular Systems, Inc. in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 71 increasing their positions, 69 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more call options, than puts

Call options by funds: $4.93M | Put options by funds: $2M

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

10% more capital invested

Capital invested by funds: $1.38B → $1.52B (+$134M)

3% more repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 69

0% more funds holding

Funds holding: 190190 (0)

Holders
190
Holders Change
Holders Change %
0%
% of All Funds
4.17%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
22
Increased
71
Reduced
69
Closed
19
Calls
$4.93M
Puts
$2M
Net Calls
+$2.93M
Net Calls Change
+$3.25M
Name Holding Trade Value Shares
Change
Change in
Stake
EGM
151
Engineers Gate Manager
New York
$239K -$2.2M -46,729 -90%
BWM
152
BerganKDV Wealth Management
Minnesota
$238K
Janus Henderson Group
153
Janus Henderson Group
United Kingdom
$235K +$1.69K +36 +0.7%
GHCM
154
Glen Harbor Capital Management
California
$230K +$228K +4,844 New
ProShare Advisors
155
ProShare Advisors
Maryland
$227K +$225K +4,783 New
HIS
156
Harvest Investment Services
Illinois
$227K +$232K +4,944 New
QIM
157
Quantitative Investment Management
Virginia
$222K +$220K +4,672 New
MCIM
158
Meadow Creek Investment Management
Georgia
$181K +$179K +3,806 New
FDCDDQ
159
Federation des caisses Desjardins du Quebec
Quebec, Canada
$179K +$95.6K +2,035 +118%
RCM
160
Riverhead Capital Management
Delaware
$143K +$141K +3,000 New
AIP
161
Ameritas Investment Partners
Nebraska
$133K
FCM
162
Flinton Capital Management
Pennsylvania
$132K +$130K +2,768 New
AG
163
Advisor Group
Arizona
$120K +$87.2K +1,856 +283%
Zurich Cantonal Bank
164
Zurich Cantonal Bank
Switzerland
$111K +$23.3K +495 +27%
PCM
165
Prelude Capital Management
New York
$91K +$84K +1,787 +1,477%
Group One Trading
166
Group One Trading
Illinois
$85K +$13.7K +291 +19%
PWP
167
Personal Wealth Partners
Minnesota
$78K -$8.22K -175 -10%
MOACM
168
Mutual of America Capital Management
New York
$62K +$2.68K +57 +5%
Walleye Trading
169
Walleye Trading
New York
$57K +$56.4K +1,200 New
QCG
170
Quadrant Capital Group
Ohio
$49K
VCM
171
Versant Capital Management
Arizona
$46K
TRCT
172
Tower Research Capital (TRC)
New York
$33K +$6.91K +147 +27%
QT
173
Quantamental Technologies
New York
$30K +$29.9K +636 New
AS
174
Altshuler Shaham
Israel
$29K -$1.74K -37 -6%
SCA
175
Stonebridge Capital Advisors
Minnesota
$29K

CSII Hedge Fund Activity: Q3 2019 in Review

190 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q3 2019, worth a combined $1.52B — up 9.7% from $1.38B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CSII positions and 19 closed out — a net gain of 3 holders — while 71 added to existing stakes and 69 trimmed.

The largest buyer was Brown Capital Management, adding an estimated $61.7M. The largest seller was Champlain Investment Partners, cutting an estimated $11.6M.

  • 190 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $1.52B of Cardiovascular Systems, Inc. stock for Q3 2019, up 9.7% quarter-over-quarter.
  • 22 funds opened new Cardiovascular Systems, Inc. positions in Q3 2019 and 19 closed out, a net change of +3 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q3 2019 was Brown Capital Management, an estimated $61.7M added.
  • The largest Cardiovascular Systems, Inc. seller in Q3 2019 was Champlain Investment Partners, an estimated $11.6M sold.

Based on aggregated 13F filings for Q3 2019.